يعرض 1 - 10 نتائج من 21 نتيجة بحث عن '"Osteoporotic Fractures/prevention & control"', وقت الاستعلام: 1.20s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المساهمون: Rheumatology, AII - Inflammatory diseases, AMS - Musculoskeletal Health, AMS - Tissue Function & Regeneration, Medical Informatics

    المصدر: BMJ (Clinical research ed.), 381:e068033. BMJ Publishing Group
    Händel, M N, Cardoso, I, von Bülow, C, Rohde, J F, Ussing, A, Nielsen, S M, Christensen, R, Body, J-J, Brandi, M L, Diez-Perez, A, Hadji, P, Javaid, M K, Lems, W F, Nogues, X, Roux, C, Minisola, S, Kurth, A, Thomas, T, Prieto-Alhambra, D, Ferrari, S L, Langdahl, B & Abrahamsen, B 2023, ' Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials ', BMJ (Clinical research ed.), vol. 381, e068033, pp. e068033 . https://doi.org/10.1136/bmj-2021-068033
    BMJ. BMJ Publishing Group
    Händel, M N, Cardoso, I, Von Bülow, C, Rohde, J F, Ussing, A, Nielsen, S M, Christensen, R, Body, J J, Brandi, M L, Diez-Perez, A, Hadji, P, Javaid, M K, Lems, W F, Nogues, X, Roux, C, Minisola, S, Kurth, A, Thomas, T, Prieto-Alhambra, D, Ferrari, S L, Langdahl, B & Abrahamsen, B 2023, ' Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials ', BMJ, vol. 381, e068033 . https://doi.org/10.1136/bmj-2021-068033

    وصف الملف: application/pdf

  4. 4

    المساهمون: CHU Toulouse [Toulouse], AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Physiopathologie, diagnostic et traitements des maladies osseuses / Pathophysiology, Diagnosis & Treatments of Bone Diseases (LYOS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier le Vinatier [Bron], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Robert Debré, Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Archives de Pédiatrie
    Archives de Pédiatrie, Elsevier, 2020, 27 (7), pp.393-398. ⟨10.1016/j.arcped.2020.07.008⟩

  5. 5
  6. 6
  7. 7
  8. 8

    المصدر: Jakobsen, P R, Hermann, A P, Søndergaard, J, Wiil, U K, Dixon, R F & Clemensen, J 2018, ' Left in limbo – Experiences and needs among postmenopausal women newly diagnosed with osteoporosis without preceding osteoporotic fractures : A qualitative study ', Post Reproductive Health, vol. 24, no. 1, pp. 26-33 . https://doi.org/10.1177/2053369118755189

  9. 9

    المساهمون: University of Zurich, Meier, Christian

    المصدر: Swiss medical weekly, vol. 147, pp. w14484
    Meier, Christian; Uebelhart, Brigitte; Aubry-Rozier, Bérengère; Birkhäuser, Martin; Bischoff-Ferrari, Heike A; Frey, Diana; Kressig, Reto W; Lamy, Olivier; Lippuner, Kurt; Stute, Petra; Suhm, Norbert; Ferrari, Serge (2017). Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO. Swiss medical weekly, 147(w14484), w14484. EMH Schweizerischer Ärzteverlag 10.4414/smw.2017.14484 <http://dx.doi.org/10.4414/smw.2017.14484>
    Swiss Medical Weekly, Vol. 147, No w14484 (2017)

    وصف الملف: application/pdf; smw-147-w14484.pdf - application/pdf

  10. 10